One hypothesis to explain how high doses of ascorbate selectively kill cancer cells while having minimal effect on non-malignant cells proposes that cancer cells have increased uptake of dehydroascorbic acid (DHA), the two-electron oxidation product of ascorbate, via increased expression of GLUT1 transporters [62]. This evidence concerns the gene SLC2A1 and cancer.